Richard J. A. Goodwin
AstraZeneca (United Kingdom)(GB)AstraZeneca (South Korea)(KR)Bioanalytica (Switzerland)(CH)AstraZeneca (Singapore)(SG)AstraZeneca (Brazil)(BR)AstraZeneca (Poland)(PL)AstraZeneca (Spain)(ES)University of Glasgow(GB)Unisys (United States)(US)
Publications by Year
Research Areas
Mass Spectrometry Techniques and Applications, Metabolomics and Mass Spectrometry Studies, Analytical Chemistry and Chromatography, Advanced Proteomics Techniques and Applications, Gut microbiota and health
Most-Cited Works
- → The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer(2021)324 cited
- → Sample preparation for mass spectrometry imaging: Small mistakes can lead to big consequences(2012)307 cited
- → Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs(2020)221 cited
- → Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo(2016)215 cited
- → Direct Targeted Quantitative Molecular Imaging of Neurotransmitters in Brain Tissue Sections(2014)214 cited
- → Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies(2019)201 cited